Colmenar Viejo, Madrid, Spain

Alfonso Latorre Lozano

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Pharma Mar, S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfonso Latorre Lozano. Retrieved from https://idiyas.com/inventor/alfonso-latorre-lozano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alfonso Latorre Lozano: Innovator in the Pharmaceutical Industry

Introduction

Alfonso Latorre Lozano is a notable inventor based in Colmenar Viejo, Spain. He is currently associated with Pharma Mar, S.A., a company that specializes in the development of innovative medicines for cancer treatment. Although he holds no patents at this time, his contributions to the field of pharmaceuticals are noteworthy.

Latest Patents

As of now, Alfonso Latorre Lozano has not registered any patents. This may reflect his focus on collaborative projects and research within his company rather than individual patent filings.

Career Highlights

Alfonso has made significant strides in his career at Pharma Mar, S.A. His work primarily revolves around the development of new therapeutic approaches for cancer treatment. His expertise in the pharmaceutical sector has positioned him as a valuable asset to his team.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Alfonso Latorre Lozano is an influential figure in the pharmaceutical industry, contributing to innovative cancer treatments through his work at Pharma Mar, S.A. His journey reflects the importance of collaboration and dedication in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…